Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank of New York Mellon Corp (BNY) vs Cytokinetics Inc (CYTK) Price & Performance

Bank of New York Mellon CorpTrade
Cytokinetics IncTrade

Price performance (Past 24H)

Key statistics

Bank of New York Mellon Corp vs Cytokinetics Inc — how do they compare? Bank of New York Mellon Corp trades at $161.02 (market cap $108.78B), while Cytokinetics Inc trades at $76.67 (market cap $10.63B). The key difference: Bank of New York Mellon Corp is far larger — about 10.2× Cytokinetics Inc's market cap, and Bank of New York Mellon Corp pays a 1.38% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.

BNYCYTK
Market Cap
$108.78B$10.63B
Sector
FinancialsTechnology
52-Week High
$162.35$87.26
52-Week Low
$101.00$34.31
Dividend Yield
1.38%
Enterprise Value
$10.74B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Bank of New York Mellon Corp

BNY Mellon is a global investment company involved in managing and servicing financial assets throughout the investment lifecycle. The bank provides financial services for institutions, corporations, and individual investors and delivers investment management and investment services in 35 countries and more than 100 markets. BNY Mellon is the largest global custody bank in the world, with about $41.1 trillion in under custody and administration (as of Dec. 31, 2020), and can act as a single point of contact for clients looking to create, trade, hold, manage, service, distribute, or restructure investments. BNY Mellon's asset-management division manages about $2.2 trillion in assets.

Read more on BNY

About Cytokinetics Inc

Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.

Read more on CYTK